You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Solid MDx revenue growth was driven primarily by sales of Aptima women's health products on the Panther and Tigris platforms.
A koala genome bank aims to increase healthy genes in its population and reduce chlamydia infections, according to Australian Geographic.
The test detects chlamydia, gonorrhea, and trichomonas from a single patient sample.
Revenues from the company’s molecular diagnostics business grew 6 percent, driven by continued strength in sales of women's health products.
The automated device was able to detect pathogens from clinical samples and can be built from a 3D printer retailing at $750 or less.
Sequences from Chlamydia trachomatis strains in northern Australia suggest trachoma infections in the eye may be caused by small changes to urogenital strains.
The firm has improved design of the system for low-resource settings and validated it on clinical chlamydia samples and extracted HIV, Ebola, and dengue samples.
The revenue increase was driven by growth in Meridian's Diagnostics segment and particularly sales of its Illumigene product line.
The CE mark is for two assays covering chlamydia, gonorrhea, and trichomonas, and which run on the BD Max system.
Meridian received the CE mark for two new Illumigene molecular diagnostic tests for Chlamydia trachomatis and Neisseria gonorrhoeae.
According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.
NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.
In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.
Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.